Clinical Trial Update: Autologous Mesenchymal Stem Cells vs. Chondrocytes for the Repair of Chondral Knee Defects [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update compares autologous mesenchymal stem cells to autologous chondrocytes for repairing chondral knee defects in Phase 1/Phase 2, with st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defect of the Knee

Drugs mentioned

• Autologous Chondrocytes (chondrocytes)
• Autologous mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz | Conditions: Articular Cartilage Lesion of the Femoral Condyle | Phase 1, Phase 2 | Status: UNKNOWN